← Leaderboards
Christina Annunziata
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasm Of Ovary”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Weiping Zou · University Of Michigan At Ann Arbor$24,295,958
- Robert C Bast · University Of Texas Md Anderson Can Ctr$22,987,143
Research focus
Malignant Neoplasm Of OvaryMalignant NeoplasmsWomanSignal TransductionPathway InteractionsCellsMutationTumorProteinsClinicIn VitroClinical TrialsCytokineGenesApoptosisDesignGrowthFamilyTissuesGene ExpressionTranscription FactorCancer CellCancer Cell LineNf-Kappa B
Grant awards (43)
Nuclear Factor-kappaB in Ovarian Cancer$979,598
ZIA · FY2023 · CA · contact PI
Immune cell control of ovarian cancer$587,759
ZIA · FY2023 · CA · contact PI
Clinical trials in womens cancers$391,839
ZIA · FY2023 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$1,009,250
ZIA · FY2022 · CA · contact PI
Immune cell control of ovarian cancer$605,550
ZIA · FY2022 · CA · contact PI
Clinical trials in womens cancers$403,700
ZIA · FY2022 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$1,005,082
ZIA · FY2021 · CA · contact PI
Immune cell control of ovarian cancer$603,049
ZIA · FY2021 · CA · contact PI
Clinical trials in womens cancers$402,032
ZIA · FY2021 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$933,882
ZIA · FY2020 · CA · contact PI
Immune cell control of ovarian cancer$560,328
ZIA · FY2020 · CA · contact PI
Clinical trials in womens cancers$373,553
ZIA · FY2020 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$710,486
ZIA · FY2019 · CA · contact PI
Immune cell control of ovarian cancer$426,291
ZIA · FY2019 · CA · contact PI
Clinical trials in womens cancers$284,195
ZIA · FY2019 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$677,683
ZIA · FY2018 · CA · contact PI
Immune cell control of ovarian cancer$406,610
ZIA · FY2018 · CA · contact PI
Clinical trials in womens cancers$271,073
ZIA · FY2018 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$717,308
ZIA · FY2017 · CA · contact PI
Immune cell control of ovarian cancer$430,385
ZIA · FY2017 · CA · contact PI
Clinical trials in womens cancers$286,923
ZIA · FY2017 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$895,338
ZIA · FY2016 · CA · contact PI
Clinical trials in womens cancers$238,757
ZIA · FY2016 · CA · contact PI
Molecular characterization of endometrial cancer$59,689
ZIA · FY2016 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$912,704
ZIA · FY2015 · CA · contact PI
Clinical trials in womens cancers$243,388
ZIA · FY2015 · CA · contact PI
Molecular characterization of endometrial cancer$60,847
ZIA · FY2015 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$887,215
ZIA · FY2014 · CA · contact PI
Clinical trials in womens cancers$236,590
ZIA · FY2014 · CA · contact PI
Molecular characterization of endometrial cancer$59,148
ZIA · FY2014 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$828,564
ZIA · FY2013 · CA · contact PI
Molecular characterization of endometrial cancer$207,141
ZIA · FY2013 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$821,257
ZIA · FY2012 · CA · contact PI
Molecular characterization of endometrial cancer$234,645
ZIA · FY2012 · CA · contact PI
Protein regulation in multiple myeloma$117,322
ZIA · FY2012 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$651,396
ZIA · FY2011 · CA · contact PI
Molecular characterization of endometrial cancer$186,113
ZIA · FY2011 · CA · contact PI
Protein regulation in multiple myeloma$93,057
ZIA · FY2011 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$447,991
ZIA · FY2010 · CA · contact PI
Protein regulation in multiple myeloma$127,998
ZIA · FY2010 · CA · contact PI
Molecular characterization of endometrial cancer$63,998
ZIA · FY2010 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$659,547
ZIA · FY2009 · CA · contact PI
Nuclear Factor-kappaB in Ovarian Cancer$513,739
Z01 · FY2008 · CA · contact PI